Time: 14:00 - 15:30 UK Time
Our next journal club features two papers on the topic of Modelling and Simulation. Please join us to hear Michael O’Kelly (IQVIA) and Carl-Fredrik Burman (Astrazeneca) present their recent work:
Michael O’Kelly, ‘Proposed best practice for projects that involve modelling and simulation’ published in Pharmaceutical Statistics Vol 16, Issue 2, March/April 2017 https://onlinelibrary.wiley.com/doi/full/10.1002/pst.1789
Carl-Fredrik Burman, ‘Modelling and simulation in the pharmaceutical industry—some reflections’ published in Pharmaceutical Statistics Vol 10, Issue 6, November/December 2011 https://onlinelibrary.wiley.com/doi/abs/10.1002/pst.523
The Chair will be Vladimir Anisimov (Amgen).
The event will be held on Thursday 26th April, 2:00-3:30pm (UK time), just block out the date and time in your calendar.
In preparation and prior to the day of the webinar, please find below the link you will need to follow in order to obtain your personal dial in details and register with the webinar software. After registering via this link, you will receive a confirmation email containing information about joining the webinar, including details on how to dial-in via the telephone.
Please ensure you allow enough time before joining to download the correct software.
Please click here to view the flyer.
To access the recording, please visit the Video-on-Demand Library.
This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.
This webinar will explore two different approaches to Correlates of Protection in vaccine development.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.
